News

RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the 13 Best Healthcare Stocks to Buy Under $10. In a report released on July 7 ...
TipRanks on MSN14h
Dyne Therapeutics price target lowered to $41 from $46 at Evercore ISI
Evercore ISI analyst Gavin Clark-Gartner lowered the firm’s price target on Dyne Therapeutics (DYN) to $41 from $46 and keeps an Outperform rating ...
Final Fantasy
For some long-time fans, one of the takeaways has been that the Japanese series should return to its roots as a turn-based ...
RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13
BioCryst Pharmaceutical Inc. (NASDAQ:BCRX) is one of the 13 Best Healthcare Stocks to Buy Under $10. On July 7, RBC Capital ...